Seek Labs Maps Measles Virus with BioSeeker™, Opening the Door to First-Ever Programmable Antiviral Therapeutic Amid Global Outbreaks

SALT LAKE CITY–(BUSINESS WIRE)–#ArtificialIntelligence–Seek Labs, a biotech company boldly seeking a healthier world through AI-powered discovery, programmable therapeutics, and point-of-care diagnostics, today announced the successful mapping of conserved therapeutic targets within the measles virus (MeV) genome using BioSeeker™, the company’s proprietary AI-powered discovery engine. Amid rising measles outbreaks worldwide, this breakthrough marks a foundational step … [Read more…]

Washington Post Ranks Aledade as Top Workplace for Sixth Consecutive Year

Honor adds to growing list of best employer awards BETHESDA, Md.–(BUSINESS WIRE)–The Washington Post has recognized Aledade, the nation’s largest network of independent value-based primary care, among the best companies to work for in their annual Top Workplaces rankings. Aledade was ranked seventh in The Washington Post’s largest employer category for the District of Columbia … [Read more…]

New Study Finds Senior Patients Managed by Women Physicians in a Value-Based Care (VBC) Model Have Equal or Better Clinical and Quality Outcomes and Less Healthcare Utilization

Research also shows a reversal of the gender pay gap under VBC WESTERVILLE, Ohio–(BUSINESS WIRE)–agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced the publication of new peer-reviewed data examining the impact of gender differences of primary care physicians (PCPs) on patient outcomes, healthcare utilization and … [Read more…]

Fujirebio Acquires Plasma Services Group and Strengthens Its Position as Provider of Critical and High Quality Biological Raw Materials to the IVD and Life Science Industries

MALVERN, Pa. & TOKYO–(BUSINESS WIRE)–#IVD–H.U. Group Holdings Inc., and its wholly owned subsidiary, Fujirebio Holdings, Inc. (hereinafter “Fujirebio”) today announced that Fujirebio Diagnostics, Inc., a subsidiary of Fujirebio, has acquired all shares of Plasma Services Group, Inc. (hereinafter “Plasma Services Group”). The transaction value has not been disclosed. Founded in 2004, Plasma Services Group has … [Read more…]

Ono Pharmaceutical and Vertex Announce Strategic Agreement to Develop and Commercialize Povetacicept in Japan and South Korea

Ono and Vertex have entered into an exclusive collaboration and license agreement for povetacicept in Japan and South Korea Povetacicept is a therapeutic in development for multiple serious B cell-mediated diseases including IgA nephropathy and primary membranous nephropathy Povetacicept is a recombinant fusion protein and a dual antagonist of the BAFF and APRIL cytokines OSAKA, … [Read more…]

NEL Animal Cardiovascular Center Achieves World’s First Surgical Correction of Complex VSD in Canine Patient

ANYANG, South Korea–(BUSINESS WIRE)–#Canine—NEL Animal Cardiovascular Center, a private 24-hour animal hospital in South Korea, said that its cardiac surgery team has successfully performed the world’s first surgical correction of a complex ventricular septal defect (VSD) in a canine patient. This veterinary milestone is highly significant, as it marks the first such case not only … [Read more…]

New Data Show Delve Bio’s Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing

Data Presented at the 2025 American Society for Microbiology Microbe Conference BOSTON–(BUSINESS WIRE)–#biotech—Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data presented at the American Society for Microbiology (ASM) Microbe conference in Los Angeles showing the impact of metagenomic sequencing for transforming infectious disease diagnostics by offering advances compared … [Read more…]

Prime Success Issues Statement on New York State Court Decision Confirming Our Rights as Sinovac Shareholders – Including Right to Vote at Upcoming Special Meeting

Corrects the Record Following Latest Attempt By the 1Globe Activist Board to Distort Reality in Transparent Attempt to Mislead Shareholders Notes That on Friday Antiguan Judge Denied the 1Globe Activist Board’s Attempt to Immediately Prevent Prime Success From Voting Sinovac Shares – Which the Board Failed to Disclose to Shareholders HONG KONG–(BUSINESS WIRE)–Prime Success L.P., … [Read more…]

GE HealthCare drives innovation in theranostics with latest technological advances

GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through a comprehensive portfolio of AI-powered imaging technologies, radiopharmaceuticals, cyclotrons, chemistry systems, and workflow-optimizing software—designed to support personalized, data-driven care across the entire patient journey. At #SNMMI25, the company is proud to introduce LesionID™ Pro with automated zero-click pre-processing,i which aims … [Read more…]

SINOVAC Board of Directors Prevails Against Advantech/Prime’s New York Lawsuit

New York Court Denies Advantech/Prime’s Petition for Emergency Injunctive Relief Clears Legal Hurdle for Dividend Paying Agent to Payout the Special Cash Dividend of US$55.00 Per Common Share on July 7, 2025 BEIJING–(BUSINESS WIRE)–SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it has prevailed … [Read more…]